The epidermal growth factor receptor (EGFR) is the most frequent type of mutation observed in NSCLC, while exon 20 insertions (ex20ins) represent the third most predominant EGFR subtype (Liu et al., 2024; Robichaux et al., 2018a). This evidence concerns the gene EGFR and non-small cell lung carcinoma.